Novel heterocyclic analogs of diphenylethylene compounds and uses thereof
CA 2410171 A1 · Owner: Neogi, Partha · Inventors: Nag, Bishwajit; Medicherla, Satyanarayana; Dey, Debendranath
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel diphenylethylene compounds and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level serum insulin, triglyceride and , free fatty acid levels in animal models of Type II diabetes. In contrast to previously reported thiazolidinedione compounds known to lower leptin levels, the present compounds increase leptin levels and have no known liver toxicity. The compounds are disclosed as useful for a variety of treatments including the treatment of inflammation, inflammatory and immunological diseases insulin resistance, hyperlipidemia, coronary artery disease cancer and , multiple sclerosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 5, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.